Filing Details
- Accession Number:
- 0001209191-22-006373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-02 16:25:04
- Reporting Period:
- 2022-01-31
- Accepted Time:
- 2022-02-02 16:25:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780561 | Elliott Jonathan Dickinson | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp, General Manager, Europe | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-31 | 7,375 | $74.19 | 30,214 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $73.61 to $74.57
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Includes an aggregate of 19,705 shares of common stock issuable pursuant topreviously reported restricted stock units that have not vested.
Billionaire Hedge Funds
